logo
Select company
Select metric
$ -0.1EBITDA per Share
VS
Market
32
Sector
71
Industry
68
History
100
$ 0.91Close
$ 0.43 - $ 1.22 52-Week Range
Ticker Information

Ticker

NMTC

Company Name

NEUROONE MEDICAL TECHNOLOGIES CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

NEUROONE MEDICAL TECHNOLOGIES CORP - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NMTC - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -4.97M$ -0.1148.6M
3/31/2025$ -6.24M$ -0.2131.11M
12/31/2024$ -6.82M$ -0.22130.84M
9/30/2024$ -11.96M$ -0.45126.76M
6/30/2024$ -11.74M$ -0.43127.35M
3/31/2024$ -12.45M$ -0.48125.91M
12/31/2023$ -13.14M$ -0.55124M
9/30/2023$ -11.55M$ -0.64118.12M
6/30/2023$ -9.82M$ -0.56117.58M
3/31/2023$ -9.14M$ -0.56116.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEUROONE MEDICAL TECHNOLOGIES CORP's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.12.
  • Over the past 5 years, NEUROONE MEDICAL TECHNOLOGIES CORP's average EBITDAPS has been $ -0.57.
  • The median EBITDAPS for NEUROONE MEDICAL TECHNOLOGIES CORP during this period was $ -0.58
  • NEUROONE MEDICAL TECHNOLOGIES CORP reached its highest EBITDAPS over the past 5 years at $ -0.1.
  • The lowest EBITDAPS recorded by NEUROONE MEDICAL TECHNOLOGIES CORP in the same timeframe $ -1.12

NEUROONE MEDICAL TECHNOLOGIES CORP's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
VVOS : VIVOS THERAPEUTICS INC $ -1.49MLSS : MILESTONE SCIENTIFIC INC $ -0.08NUWE : NUWELLIS INC $ -18.64MODD : MODULAR MEDICAL INC $ -0.36VERU : VERU INC $ -2.18HIND : VYOME HOLDINGS INC $ -15.17XAIR : BEYOND AIR INC $ -7.15IVF : INVO FERTILITY INC $ -65.58CUE : CUE BIOPHARMA INC $ -0.38BCAB : BIOATLA INC $ -1

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for NEUROONE MEDICAL TECHNOLOGIES CORP is calculated as follows: EBITDA [ $ -6.05M ] / (Shares WA [ 5.42M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.12 ]

NMTC - EBITDA per Share, Last 5 years

$ -1.12

Minimum

Sep 30, 2020

$ -0.1

Maximum

Jun 30, 2025

$ -0.57

Average

$ -0.58

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.02 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.02
median$ 0.99
std$ 4.26